PPARA and hepatocellular carcinoma: Long-term pharmacological activation of PPARα by Wy-14,643 in mice leads to marked peroxisome proliferation, hepatocyte hyperplasia, and a high incidence of hepatocellular carcinoma (HCC) in over 70% of wild-type mice.